ACH Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03
Prezzo $0.51
Intervallo 52 sett. $1–$6

ACH Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04
intervallo
barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 7
Data ex-dividendo Split Tipo
01 Aprile 2010 3-for-2 Avanti
09 Giugno 1994 3-for-2 Avanti
23 Marzo 1993 3-for-2 Avanti
17 Luglio 1991 3-for-2 Avanti
01 Giugno 1988 3-for-2 Avanti
03 Settembre 1985 3-for-2 Avanti
01 Novembre 1982 2-for-1 Avanti

Informazioni su Accendra Health, Inc. Common Stock Panoramica della società da Wikipedia

05 · wikidata

Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.

History

Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.

In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.

By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.

In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.

In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.

In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.

Personnel

On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.

Richmond, Virginia center

In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.

Movianto

In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.

Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.

In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.

On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.

Divest of P&HS - Rebrand Accendra Health, Inc.

On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti6.500 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06
Ricavi·
2015-12-31 → 2022-12-31
EPS·
2019-12-31 → 2022-12-31
Flusso di cassa libero·
2019-12-31 → 2022-12-31
Margine netto·
2019-12-31 → 2022-12-31
Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Nessun dato per questo gruppo di rapporti al momento

Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

13
Pagamento annualizzato≈$0.01Pagato trimestralmente
Data ex-dividendoImportoValutaRendimento
Dic 14, 2021$0,00USD≈0.03%
Set 14, 2021$0,00USD≈0.03%
Giu 14, 2021$0,00USD≈0.03%
Mar 12, 2021$0,00USD≈0.03%
Dic 14, 2020$0,00USD≈0.04%
Set 14, 2020$0,00USD≈0.08%
Giu 12, 2020$0,00USD≈0.16%
Mar 13, 2020$0,00USD≈0.28%
Dic 13, 2019$0,00USD≈1.6%
Set 13, 2019$0,00USD≈5.5%
Giu 13, 2019$0,00USD≈20.8%
Mar 14, 2019$0,00USD≈12.6%
Dic 14, 2018$0,08USD≈13.2%
Set 14, 2018$0,26USD≈6.4%
Giu 14, 2018$0,26USD≈6.4%
Mar 14, 2018$0,26USD≈6.2%
Dic 14, 2017$0,26USD≈5.5%
Set 14, 2017$0,26USD≈3.6%
Giu 13, 2017$0,26USD≈3.2%
Mar 13, 2017$0,26USD≈2.9%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14
Sorpresa media -6.8%
Prossimo report Ott 28, 2026
PeriodoRapportoEPS ActualEPS StimatoSorpresa
30 Giugno 2026 Ago 10, 2026 $-0.19 $-0.09 -113.0%
31 Marzo 2026 $-0.04 $-0.10 60.9%
31 Dicembre 2025 $0.21 $0.22 -5.8%
30 Settembre 2025 $0.25 $0.23 6.7%
30 Giugno 2025 $0.26 $0.28 -6.3%
31 Marzo 2025 $0.23 $0.20 16.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15
Conto Economico 16
Metrica Tendenza 2022202120202019201820172016
Revenue $290.99B$298.89B$203.99B$190.22B$180.35B$181.02B$144.85B
Cost of Revenue $259.70B$264.17B$188.52B$179.28B$167.11B$166.29B$133.70B
Gross Profit $31.28B$34.72B$15.47B$10.93B$13.24B$14.73B$11.15B
R&D Expense $4.81B$2.42B$1.47B$941M$627M$498M$169M
SG&A Expense $6.01B$6.33B$5.06B$3.97B$3.98B$4.55B·
Operating Income $16.39B$18.67B$7.60B$6.21B$6.82B··
Interest Expense $3.83B$4.51B$4.99B$4.38B$4.69B$4.83B$4.76B
Interest Income $477M$311M$266M$261M$492M$707M$816M
Pretax Income $13.21B$14.19B$2.89B$1.87B$2.27B$3.05B$1.62B
Income Tax $2.37B$2.87B$641M$632M$826M$644M$404M
Net Income $4.19B$5.76B$862M$596M$709M$1.41B$366M
EPS (Basic) $0.24$0.33$0.03$0.02$0.03$0.09$0.02
EPS (Diluted) $0.24$0.33$0.03$0.02···
Shares (Basic) 17,022,67317,022,67317,022,67317,022,67316,842,71414,903,798,23614,903,798,236
Shares (Diluted) ···17,022,672,95116,842,713,73814,903,798,23614,903,798,236
EBITDA $16.39B$13.41B$6.02B····
Stato Patrimoniale 11
Metrica Tendenza 2022202120202019201820172016
Cash & Equivalents $16.82B$19.68B$9.67B$7.78B$19.13B$27.85B$23.85B
Receivables $5.87B$7.11B$9.31B$7.42B$8.10B··
Inventory $24.71B$21.64B$19.86B$19.52B$20.46B$20.55B$17.93B
Current Assets $54.54B$54.11B$46.27B$48.70B$58.90B$68.64B$66.49B
PP&E (Net) $109.28B$121.38B$130.93B$103.49B$99.61B$95.73B$90.37B
Goodwill $3.50B$3.51B$3.51B····
Total Assets $212.35B$224.86B$195.04B$203.14B$200.96B$199.82B$190.51B
Current Liabilities $62.37B$61.92B$62.63B$69.20B$74.84B$90.34B$83.18B
Total Liabilities $124.59B$135.17B$123.74B$132.38B$133.30B$134.07B$134.72B
Retained Earnings $10.09B$6.81B$-1.98B$-2.21B$-2.86B$-3.33B$-4.64B
Stockholders' Equity $54.40B$60.48B$54.45B$54.67B$52.42B$39.69B$38.17B
Flusso di cassa 8
Metrica Tendenza 2022202120202019201820172016
D&A ····$8.06B$7.06B$7.00B
Operating Cash Flow $27.75B$35.16B$19.42B$12.51B$13.02B$13.21B$11.61B
CapEx $4.42B$3.19B$10.33B$9.05B$6.75B$8.89B$6.33B
Investing Cash Flow $-3.42B$-1.67B$-3.31B$-13.40B$-5.53B$-5.60B$-2.63B
Dividends Paid $2.51B$579M$423M$223M$328M$309M$20M
Financing Cash Flow $-27.04B$-23.41B$-18.23B$-10.47B$-16.28B$-3.39B$-6.11B
Free Cash Flow $23.33B$26.19B$9.84B$3.58B···
Levered FCF $20.19B$23.50B$7.02B$501M···
Redditività 8
Metrica Tendenza 2022202120202019201820172016
Gross Margin 10.8%9.8%7.2%6.4%···
Operating Margin 5.6%5.0%3.2%····
Net Margin 1.4%1.9%0.40%0.45%···
Pretax Margin 4.5%3.8%1.2%1.1%···
EBITDA Margin 5.6%5.0%3.2%····
ROA 1.9%2.6%0.37%0.42%···
ROE 7.3%9.1%1.4%1.6%···
ROIC 24.7%17.9%8.1%····
Liquidità e Solvibilità 3
Metrica Tendenza 2022202120202019201820172016
Current Ratio 0.90.90.70.7···
Quick Ratio 0.40.50.30.2···
Interest Coverage 4.33.81.6····
Efficienza 3
Metrica Tendenza 2022202120202019201820172016
Asset Turnover 1.31.40.90.9···
Inventory Turnover 11.212.68.88.9···
Receivables Turnover 44.833.322.324.5···
Per Azione 3
Metrica Tendenza 2022202120202019201820172016
Revenue / Share ···$11.17···
Cash Flow / Share ···$0.73···
EPS (TTM) $0.24$0.29$0.03$0.02···
Valutazione (TTM) 6
Metrica Tendenza 2022202120202019201820172016
Revenue TTM $290.99B$269.75B$185.99B$190.22B···
Net Income TTM $4.19B$5.08B$764M$596M···
P/E 81.7152.1901.7235.0···
Earnings Yield 1.2%0.66%0.11%0.43%···
Payout Ratio 60.0%9.1%48.1%26.2%···
Annual Payout $2.51B$461M$356M$223M···

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16
Metrica 2022-12-312021-12-312020-12-312019-12-312018-12-31
Ricavi $290.99B $298.89B $203.99B $190.22B $180.35B
Margine Lordo % 10.8% 9.8% 7.2% 6.4% ·
Margine Operativo % 5.6% 5.0% 3.2% · ·
Utile netto $4.19B $5.76B $862M $596M $709M
EPS Diluito $0.24 $0.33 $0.03 $0.02 ·

Proprietari istituzionali (13F) 161 filer · $236.6M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 161
Valore detenuto $236.6M
Nuove posizioni 22
Posizioni chiuse 21
Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
22 (-7 vs trimestre precedente) 21 (-25 vs trimestre precedente) 47 (+8 vs trimestre precedente) 45 (-7 vs trimestre precedente) -61K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
Coliseum Capital Management, LLC $44.804.760 13.100.807 18,94% Azioni
BlackRock, Inc. $18.824.028 5.504.102 7,96% Azioni
VANGUARD GROUP INC $17.691.199 6.318.285 7,48% Azioni
BANK OF AMERICA CORP /DE/ $12.912.296 3.775.525 5,46% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $10.560.724 3.087.931 4,46% Azioni
D. E. Shaw & Co., Inc. $10.538.412 3.081.407 4,45% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $9.877.158 2.888.058 4,17% Azioni
Invenomic Capital Management LP $9.618.661 2.812.474 4,07% Azioni
MARSHALL WACE, LLP $8.832.423 2.582.579 3,73% Azioni
PARADIGM CAPITAL MANAGEMENT INC/NY $8.675.511 2.536.699 3,67% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $6.945.870 2.030.956 2,94% Azioni
Dana Investment Advisors, Inc. $6.650.556 1.944.607 2,81% Azioni
GEODE CAPITAL MANAGEMENT, LLC $6.408.062 1.873.127 2,71% Azioni
DIMENSIONAL FUND ADVISORS LP $5.609.358 1.640.163 2,37% Azioni
STATE STREET CORP $5.475.974 1.601.162 2,31% Azioni
Connor, Clark & Lunn Investment Management Ltd. $4.407.652 1.288.787 1,86% Azioni
AQR CAPITAL MANAGEMENT LLC $3.650.249 1.067.324 1,54% Azioni
GOLDMAN SACHS GROUP INC $2.923.176 854.730 1,24% Azioni
TWO SIGMA INVESTMENTS, LP $2.457.441 718.550 1,04% Azioni
NORTHERN TRUST CORP $1.989.770 581.804 0,84% Azioni
WOLVERINE ASSET MANAGEMENT LLC $1.942.847 568.084 0,82% Azioni
TUDOR INVESTMENT CORP ET AL $1.939.995 567.250 0,82% Azioni
JANE STREET GROUP, LLC $1.833.462 536.100 0,77% Opzione Call
Vanguard Global Advisers, LLC $1.742.463 509.492 0,74% Azioni
VANGUARD FIDUCIARY TRUST CO $1.665.913 487.109 0,70% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1.575.252 460.600 0,67% Opzione Call
TWO SIGMA ADVISERS, LP $1.518.922 542.472 0,64% Azioni
BW Gestao de Investimentos Ltda. $1.446.971 423.091 0,61% Azioni
CITADEL ADVISORS LLC $1.321.919 386.526 0,56% Azioni
CITADEL ADVISORS LLC $1.191.528 348.400 0,50% Opzione Call
Nebula Research & Development LLC $1.115.105 122.539 0,47% Azioni
RENAISSANCE TECHNOLOGIES LLC $1.109.492 324.413 0,47% Azioni
MORGAN STANLEY $1.052.342 307.701 0,44% Azioni
Linden Thomas Advisory Services, LLC $932.501 272.661 0,39% Azioni
Bank of New York Mellon Corp $917.257 268.204 0,39% Azioni
Nuveen, LLC $803.515 234.946 0,34% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $794.692 232.366 0,34% Azioni
Kennondale Capital Management LLC $772.544 225.890 0,33% Azioni
STRS OHIO $716.148 209.400 0,30% Azioni
MILLENNIUM MANAGEMENT LLC $690.902 202.018 0,29% Azioni
Cubist Systematic Strategies, LLC $593.424 123.630 0,25% Azioni
BNP PARIBAS FINANCIAL MARKETS $546.095 159.677 0,23% Azioni
WELLS FARGO & COMPANY/MN $542.754 158.700 0,23% Azioni
XTX Topco Ltd $503.725 147.288 0,21% Azioni
ARISTEIA CAPITAL, L.L.C. $447.391 130.816 0,19% Azioni
Invesco Ltd. $446.351 130.512 0,19% Azioni
Man Group plc $436.009 127.488 0,18% Azioni
RAYMOND JAMES FINANCIAL INC $408.047 119.312 0,17% Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC $362.520 106.000 0,15% Azioni
Allspring Global Investments Holdings, LLC $356.879 99.687 0,15% Azioni

Mostra tutti i 161 proprietari istituzionali →

Proprietà ETF Posseduti da 18 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
VFVA · VANGUARD WELLINGTON FUND 0,17% 426.785 SH 19 Agosto 2026 Giornaliero
QIDX · Spinnaker ETF Series 0,11% 14.310 NS 31 Luglio 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0,02% 62.833 SH 19 Agosto 2026 Giornaliero
IWC · iShares Trust 0,02% 248.081 SH 11 Settembre 2026 Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 414.904 SH 19 Agosto 2026 Giornaliero
DFSV · Dimensional ETF Trust 0,01% 233.042 NS 31 Luglio 2026 N-PORT
RSSL · Global X Funds 0,01% 34.414 NS 31 Luglio 2026 N-PORT
DFAT · Dimensional ETF Trust 0,00% 134.690 NS 31 Luglio 2026 N-PORT
IWM · iShares Trust 0,00% 1.902.936 SH 11 Settembre 2026 Giornaliero
PRF · Invesco Exchange-Traded Fund Trust 0,00% 96.796 SH 01 Ottobre 2026 Giornaliero
DFAS · Dimensional ETF Trust 0,00% 29.296 NS 31 Luglio 2026 N-PORT
ITOT · iShares Trust 0,00% 105.616 SH 08 Settembre 2026 Giornaliero
IWV · iShares Trust 0,00% 19.827 SH 03 Settembre 2026 Giornaliero
VXF · VANGUARD INDEX FUNDS 0,00% 833.270 SH 19 Agosto 2026 Giornaliero
VTI · VANGUARD INDEX FUNDS 0,00% 2.185.973 SH 19 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 6.453 SH 19 Agosto 2026 Giornaliero
VHT · VANGUARD WORLD FUND 0,00% 184.892 SH 19 Agosto 2026 Giornaliero
IWN · iShares Trust · 666.394 SH 11 Settembre 2026 Giornaliero

ACH Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21
rating · 13 analisti VENDI
Target mediano $1.50 +196,9%
0 0,0% Acquisto forte
0 0,0% Compra
6 46,2% Mantieni
6 46,2% Vendi
1 7,7% Vendita forte

Target Price a 12 Mesi

4 analisti · 2026-09-30

Target medio $1.51 +199,4%

← Sotto tutti i target Prezzo attuale $0.51
Basso$1.30 Media$1.51 Alto$1.75

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
ACH · · · · · ·
HSIC $8.81B 23.3 4.0% 3.0% 12.0% 31.1%
AHCO $1.35B -19.2 -0.49% -2.2% -4.6% ·
MEDS · · · · · ·
ZSTK $7M -0.1 -0.53% -335.6% -319.0% 4.6%
MCK $242.30B 22.5 12.4% 1.2% -224.3% 3.6%

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Fonte: SEC 20-F/A depositato Gen 24, 2024